BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3216522)

  • 21. [Refractory anemia with excess of blasts (RAEB) and erythroleukemia (M6) in two brothers].
    Takahira H; Ogo J; Nishimura J; Ibayashi H; Umemura T; Hirata J; Toyomura M; Asayama R
    Rinsho Ketsueki; 1988 Mar; 29(3):395-401. PubMed ID: 3165146
    [No Abstract]   [Full Text] [Related]  

  • 22. Myelodysplastic syndrome with thrombocytosis in a patient with Klinefelter's syndrome.
    Yamauchi K
    Acta Haematol; 1993; 89(1):43-5. PubMed ID: 8480486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-analysis of prognosis in refractory anemia alone, with ring sideroblasts, and with excess of blasts.
    Oguma S; Yoshida Y; Uchino H; Okuma M; Maekawa T; Nomura T
    Int J Hematol; 1993 Jan; 57(1):15-25. PubMed ID: 8477059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A differentiation potency of blasts in chronic myelogenous leukemia in blastic crisis to megakaryocytic lineage].
    Sato T; Kanbayashi H; Kawaguchi M; Shiga Y; Abe R; Matsuda S; Uchida T; Kariyone S; Ohto H; Maeda H
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1360-7. PubMed ID: 3469857
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mast cell leukemia evolved from RAEB-T (5q-syndrome) in a 12 year-old girl].
    Sugita K; Kaneko T; Sekine Y; Taguchi N; Miyauchi J
    Rinsho Ketsueki; 1996 May; 37(5):430-6. PubMed ID: 8691590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD 34 immunotyping of blasts in myelodysplasia.
    Oertel J; Oertel B; Beyer J; Huhn D
    Ann Hematol; 1994 Feb; 68(2):77-80. PubMed ID: 7511934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating micromegakaryocytes in myelodysplasia.
    Erber WN; Jacobs A; Oscier DG; O'Hea AM; Mason DY
    J Clin Pathol; 1987 Nov; 40(11):1349-52. PubMed ID: 3320097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association of diabetes insipidus with a myelodysplastic syndrome prior to its transformation to acute leukemia].
    Alvarez Román M; Canales Albendea A; Aguado Romeo MJ; Hernández Navarro F
    Sangre (Barc); 1998 Jun; 43(3):266-7. PubMed ID: 9741244
    [No Abstract]   [Full Text] [Related]  

  • 30. Dysregulated expression of Bcl-xL in CD34+ cells isolated from patients with refractory anemia with excess of blasts during megakaryocytic differentiation.
    Martini M; Luongo M; Teofili L; Di Mario A; Leone G; Larocca LM
    Haematologica; 2002 Dec; 87(12):1342-3. PubMed ID: 12495906
    [No Abstract]   [Full Text] [Related]  

  • 31. Refractory anaemia with excess blasts (RAEB) in a child--an unusual clinicohaematological presentation--a case report.
    Narayan S; Sharma S; Chandra J; Gautam S; Banga V
    Indian J Pathol Microbiol; 2001 Jul; 44(3):369-70. PubMed ID: 12024939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Megakaryoblastic lineage of peripheral blood blasts of CML blast crisis identified by budding dysplastic platelets.
    Anand M; Kumar R; Singh S
    Am J Hematol; 2004 Apr; 75(4):239-40. PubMed ID: 15054817
    [No Abstract]   [Full Text] [Related]  

  • 33. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
    Lemez P; Gáliková J; Haas T
    Vnitr Lek; 1999 Jun; 45(6):342-6. PubMed ID: 11045169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
    Hancock JC; Prchal JT; Bennett JM; Listinsky CM
    Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytogenetic studies in myelodysplasias].
    Grebe G; Legues ME; Veloso M; Morizon G; Chuecas F; Lira P
    Rev Med Chil; 1991 Dec; 119(12):1396-402. PubMed ID: 9723096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
    Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
    Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of myelodysplastic syndrome and multiple myeloma.
    Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
    Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
    Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
    Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.